For the Inventor, By the Inventor

Enter assignee name

Pharming Intellectual Property Bv

USPTO Granted Patents = 11

EPO Patents = 7

Trademarks = 10

Forward Citations = 96

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Johannes Henricus Nuijens (5 out of 5 patents)

Frank Pieper (4 out of 7 patents)

Maurice Mannesse (3 out of 3 patents)

4. Maria Grazia De Simoni (3 out of 3 patents)

5. Gijsbertus Johannes Ziere (3 out of 3 patents)

6. Graham McCreath (2 out of 4 patents)

7. Erik Jordahl Forsberg (1 out of 7 patents)

8. Kathryn Margaret Nelson (1 out of 1 patent)

9. Michael William Mosesson (1 out of 1 patent)

10. Anthony Pusateri (1 out of 1 patent)

11. Mourad Salaheddine (1 out of 1 patent)

12. Marc Peter Elvira Maria Klyutmans (1 out of 1 patent)

13. Pieter Cornelis Johannes Maria Streng (1 out of 1 patent)

14. Udell Michael (1 out of 1 patent)

15. Jan Henricus Nuijens (1 out of 3 patents)

11 patents: Sort by Forward Citations

1. 9546381 - Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals (2017-01-17),

2. 9408366 - Milking device (2016-08-09),

3. 9211318 - Use of C1 inhibitor for the prevention of ischemia-reperfusion injury (2015-12-15),

4. 8415288 - Use of C1 inhibitor for the prevention of ischemia-reperfusion injury (2013-04-09),

5. RE43691 - C1 inhibitor with short half-life transient treatment (2012-09-24),

6. 8071532 - Use of C1 inhibitor for the prevention of ischemia-reperfusion injury (2011-12-06),

7. RE42704 - Production of fibrinogen in transgenic animals (2011-09-12),

8. 7544853 - C1 inhibitor with short half-life transient treatment (2009-06-09),

9. 7211650 - Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography (2007-05-01),

10. 7067713 - C1 Inhibitor produced in the milk of transgenic non-human mammals (2006-06-27),

11. 7045677 - Fusion proteins incorporating lysozyme (2006-05-16),

Pharming Intellectual Property Bv is a biotech company specializing in the development of innovative protein therapies. With a focus on rare diseases and unmet medical needs, Pharming is dedicated to improving the lives of patients worldwide. Their proprietary technology platform allows for the production of recombinant proteins in a cost-effective manner, making life-saving treatments more accessible.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#31 in

#561 in Netherlands

#50,238 in the World

Pharming Intellectual Property Bv

Forward Citations = 96

20 inventors:

Johannes Henricus Nuijens (5 out of 5 patents)

Frank Pieper (4 out of 7 patents)

Maurice Mannesse (3 out of 3 patents)

4. Maria Grazia De Simoni (3 out of 3 patents)

5. Gijsbertus Johannes Ziere (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…